Jagsonpal Pharma Expands into Hospital Market with Aequitas Healthcare Acquisition
Advertisement
Jagsonpal Pharma will invest INR 20.8 Cr through internal accruals to acquire the majority stake, while the remaining 15% equity will continue to be held by Aequitas Healthcare.
Gurugram-based Jagsonpal Pharma has signed a definitive agreement to acquire an 85% equity stake in Mumbai-based Aequitas Healthcare, marking its entry into the hospital pharmaceutical business.
The INR 20.8 Cr acquisition is expected to help the company expand beyond its traditional prescription portfolio by leveraging Aequitas Healthcare's strong relationships with hospital networks across India.
Manish Gupta, Managing Director, Jagsonpal, stated, "The proposed acquisition of Aequitas represents an important strategic milestone for Jagsonpal. It provides us with a ready platform for a meaningful presence in the hospital segment, which now contributes ~10% of pharma industry sales and is growing faster.
Founded in 2017, Mumbai-based Aequitas Healthcare focuses on supplying pharmaceutical products to leading hospital chains across India. Through the acquisition, Jagsonpal Pharma is expected to gain immediate access to this hospital distribution network instead of building one from the ground up.
Shailesh Kamat, Director and the largest shareholder of Aequitas Healthcare, said, “Over the past eight years, we have built a strong institutional business supported by a quality product portfolio and long-standing customer relationships. Partnering with Jagsonpal gives us the opportunity to accelerate growth while creating greater value for customers, employees and the wider healthcare ecosystem,” he said.
Under the agreement, Jagsonpal Pharma will invest INR 20.8 Cr through internal accruals to acquire the majority stake, while the remaining 15% equity will continue to be held by Aequitas Healthcare's existing directors, who will remain associated with the business and continue supporting its operations.
The transaction is expected to close by July 15, 2026, subject to customary conditions.
Stay tuned for more such updates on Digital Health News
